BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8335399)

  • 1. Intra-uterine contraception and the risk of endometrial cancer.
    Castellsagué X; Thompson WD; Dubrow R
    Int J Cancer; 1993 Jul; 54(6):911-6. PubMed ID: 8335399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine device use and endometrial cancer risk.
    Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
    Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer in relation to intra-uterine device use.
    Hill DA; Weiss NS; Voigt LF; Beresford SA
    Int J Cancer; 1997 Jan; 70(3):278-81. PubMed ID: 9033627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine device use and risk of endometrial cancer.
    Parazzini F; La Vecchia C; Moroni S
    Br J Cancer; 1994 Oct; 70(4):672-3. PubMed ID: 7917915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive cervical cancer and intrauterine device use.
    Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
    Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IUD use and the risk of endometrial cancer.
    Benshushan A; Paltiel O; Rojansky N; Brzezinski A; Laufer N
    Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):166-9. PubMed ID: 12381481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubal sterilization and the risk of endometrial cancer.
    Castellsague X; Thompson WD; Dubrow R
    Int J Cancer; 1996 Mar; 65(5):607-12. PubMed ID: 8598311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
    Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
    Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception and tubal sterility of infective origin].
    Gayer ML; Henry-Suchet J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):155-64. PubMed ID: 2324437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
    Felix AS; Gaudet MM; La Vecchia C; Nagle CM; Shu XO; Weiderpass E; Adami HO; Beresford S; Bernstein L; Chen C; Cook LS; De Vivo I; Doherty JA; Friedenreich CM; Gapstur SM; Hill D; Horn-Ross PL; Lacey JV; Levi F; Liang X; Lu L; Magliocco A; McCann SE; Negri E; Olson SH; Palmer JR; Patel AV; Petruzella S; Prescott J; Risch HA; Rosenberg L; Sherman ME; Spurdle AB; Webb PM; Wise LA; Xiang YB; Xu W; Yang HP; Yu H; Zeleniuch-Jacquotte A; Brinton LA
    Int J Cancer; 2015 Mar; 136(5):E410-22. PubMed ID: 25242594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine devices and endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Contraception; 1996 Dec; 54(6):329-32. PubMed ID: 8968660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
    Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
    Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of the uterine mucosa during long-term intrauterine contraception].
    Petrov IuA
    Sov Med; 1986; (5):103-4. PubMed ID: 3726613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.